Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.
about
Pathogenesis of human immunodeficiency virus infectionPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationHIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsAnimal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesThe human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infectionPersistent infection of macaques with simian-human immunodeficiency virusesInfectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shufflingChanges in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cellsIn vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.Simian-human immunodeficiency virus (SHIV) containing the nef/long terminal repeat region of the highly virulent SIVsmmPBj14 causes PBj-like activation of cultured resting peripheral blood mononuclear cells, but the chimera showed No increase in virOral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS.Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaquesAssociation of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo.Species-specific, postentry barriers to primate immunodeficiency virus infection.Characterization of primary isolate-like variants of simian-human immunodeficiency virusEnvelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virusAnimal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.Variability of bio-clinical parameters in Chinese-origin Rhesus macaques infected with simian immunodeficiency virus: a nonhuman primate AIDS modelPersistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropismRelationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infectionMolecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.Current progress in the development of a prophylactic vaccine for HIV-1.Non-human primate models for AIDS vaccine research.Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibilityHuman immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.
P2860
Q24634681-871A70A0-202E-47D0-B258-9B1E8D7A3ADCQ24646818-5387BA6C-4E90-4F82-A6D2-6B0855598890Q24682714-C07103D0-5554-4F4D-AC67-F090FFAC0C07Q26777022-B96A5462-B092-48AA-B5D2-5E9BF2F53A99Q27021655-3B52C21B-D983-4F4F-BA03-E84093720AAFQ28378949-03DC97E7-ED27-4137-8034-69FECD7A9439Q28646867-0FE17705-AD39-4A86-9949-4C783B6B7C0EQ28775731-C3A70AD0-E557-40CE-9498-08CD9EB36CF8Q30329167-6498EE5B-2E95-40C9-8542-DA5B17E83A82Q30818112-8E83096F-9B99-41E6-83A4-C11EC2576E2EQ33640139-6E9FDB8B-2D41-4650-B588-6F100207C56DQ33645053-D923D5D3-013E-4596-AB75-3FF167C05848Q33647300-9A6049D2-AFA6-442B-8FF1-BBB7EAF98BB6Q33737723-26EDFC16-5E92-451A-8B6C-10C52422D40BQ33783369-F08F2BCF-CBFA-4693-846F-E230F4B1B9B0Q33783516-3EE71A1C-3270-44D3-BC0F-6105DABBAEDBQ33784667-5615496F-921C-42DF-A326-79DF4ABB3AE2Q33785371-FD892558-E967-4F8C-A291-4D5EDF5F3541Q33787256-76DD50D3-997B-48CD-9914-9A5F9273C1C0Q33803217-C7150025-81C7-42EC-AE85-8FC645757495Q33807885-141E1908-0270-4741-B849-A77D6A5CC2D3Q33808774-DC3DDCE1-1139-4DB3-978E-012B52FD2C2EQ33810425-7BC9936B-0AC6-484C-9090-FD1DB053FAFBQ33813212-5A8CA16A-D46A-4FE8-9F7A-6BEC33C92438Q33824990-539692BC-225D-4224-98DD-6466B368BE68Q33825229-8876FF59-C482-48C5-91D0-3189C4769842Q33839485-DA3E6F72-06FA-45F9-8F41-F0B3D4CEAE5CQ33842020-D98D23C2-96B0-4138-A93C-DD8F6EDE87A3Q33957283-1AE41C1C-9A65-4F18-9DB6-A717C15CB4DEQ33995660-F9C27ED2-C128-4DBE-90B1-AE9B3DE190EAQ34060230-1363B99E-CDDA-4515-8DAA-802C2D5E1A86Q34070178-0972AAA5-1BDA-4B44-AC89-66614CB34AE8Q34154693-550316A1-362C-491C-9D84-3834429F5DEFQ34177387-8C5FDF61-0174-4867-82AC-FDB786A338FDQ34338411-041E7766-2722-427F-8938-571BB2E2C71EQ34462276-AFD71AB2-DB82-4558-BE29-869CA742450DQ34502108-AF4A476C-9B92-442C-AC32-1552E50C988BQ34715769-F7BEDD08-9F44-4DB1-95B9-0F7FDAF12B44Q34755001-754FEA62-BC10-4ACC-815F-B3D00734EE65Q35076592-ED29BD7E-E3C9-4042-B325-A0CEB6AE3B17
P2860
Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@en
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@nl
type
label
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@en
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@nl
prefLabel
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@en
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@nl
P2093
P1476
Infection of cynomolgus monkey ...... HIV-1 envelope glycoproteins.
@en
P2093
P304
P577
1992-01-01T00:00:00Z